Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-02

Clinical Trial Update: Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of Clostridium botulinum toxin type A for improving moderate to severe glabellar lines; results posted after complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clostridium botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: Ipsen | Conditions: Moderate to Severe Glabellar Lines | Phase 3 | Status: COMPLETED | Results posted: 2017-10-02